| Period Ending | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 | Apr 29, 2012 |
|---|
|
Total Revenue
|
866
|
1,360
|
982
|
1,389
| | Cost of Revenue | 890 | 1,246 | 980 | 1,364 | | |
Gross Profit
|
(24)
|
114
|
3
|
25
| |
|
Operating Expenses |
|
Research Development | 602 | 2,938 | 1,927 | 1,786 |
|
Selling General and Administrative | 2,368 | 2,105 | 2,384 | 2,416 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(2,994)
|
(4,928)
|
(4,309)
|
(4,178)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 44 | 138 | (53) | 65 |
|
Earnings Before Interest And Taxes | (2,951) | (4,791) | (4,362) | (4,113) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (2,951) | (4,791) | (4,362) | (4,113) |
|
Income Tax Expense | (1,453) |
-
|
-
|
-
|
|
Minority Interest | 31 | 39 | 26 | 17 |
|
|
|
Net Income From Continuing Ops | (1,466) | (4,752) | (4,336) | (4,096) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(1,466)
|
(4,752)
|
(4,336)
|
(4,096)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(1,466)
|
(4,752)
|
(4,336)
|
(4,096)
|
|
0.01(0.62%) 3:16PM EDT - Nasdaq Real Time Price